Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.79%
0%
-1.79%
6 Months
-8.11%
0%
-8.11%
1 Year
-1.3%
0%
-1.3%
2 Years
-18.88%
0%
-18.88%
3 Years
-53.1%
0%
-53.1%
4 Years
-55.7%
0%
-55.7%
5 Years
-66.74%
0%
-66.74%
Qingdao Haier Biomedical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.25%
EBIT Growth (5y)
-9.78%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.36
Sales to Capital Employed (avg)
0.53
Tax Ratio
4.76%
Dividend Payout Ratio
40.52%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
35.57%
ROE (avg)
14.04%
Valuation key factors
Factor
Value
P/E Ratio
37
Industry P/E
Price to Book Value
2.38
EV to EBIT
48.99
EV to EBITDA
28.54
EV to Capital Employed
3.24
EV to Sales
3.85
PEG Ratio
NA
Dividend Yield
1.46%
ROCE (Latest)
6.61%
ROE (Latest)
6.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
652.10
567.50
14.91%
Operating Profit (PBDIT) excl Other Income
66.40
67.30
-1.34%
Interest
0.90
1.00
-10.00%
Exceptional Items
0.50
-2.50
120.00%
Consolidate Net Profit
80.00
53.00
50.94%
Operating Profit Margin (Excl OI)
101.80%
61.70%
4.01%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.91% vs 0.32% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 50.94% vs -3.46% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,315.80
2,269.50
2.04%
Operating Profit (PBDIT) excl Other Income
301.80
404.30
-25.35%
Interest
7.10
4.90
44.90%
Exceptional Items
-0.30
7.10
-104.23%
Consolidate Net Profit
255.10
381.00
-33.04%
Operating Profit Margin (Excl OI)
75.10%
124.20%
-4.91%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.04% vs 0.12% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -33.04% vs -7.55% in Dec 2024
About Qingdao Haier Biomedical Co., Ltd. 
Qingdao Haier Biomedical Co., Ltd.
Industrial Manufacturing
No Details Available.
Company Coordinates 
No Company Details Available






